Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Fortis board accepts resignations of Singh brothers

      Fortis board accepts resignations of Singh brothers

      Medical Dialogues Bureau14 Feb 2018 1:25 PM IST
      Fortis Healthcare today said its board has accepted the resignations of promoters Malvinder Mohan Singh and Shivinder Mohan Singh.The board of...
      Local stent makers welcome NPPA price ceiling

      Local stent makers welcome NPPA price ceiling

      Medical Dialogues Bureau14 Feb 2018 1:24 PM IST
      New Delhi: The government' decision to revise ceiling prices of bare metal stents and drug-eluting ones has evoked mixed reactions from the medical...
      Lupin launches generic influenza treatment capsules in the US

      Lupin launches generic influenza treatment capsules in the US

      Medical Dialogues Bureau13 Feb 2018 11:00 AM IST
      New Delhi: Drug firm Lupin said it has launched in the US market its generic Oseltamivir Phosphate capsules, used for the treatment of influenza.The...
      Clinivantage Healthcare, SAH Global announce strategic partnership

      Clinivantage Healthcare, SAH Global announce strategic partnership

      Medical Dialogues Bureau13 Feb 2018 10:00 AM IST
      Pune: Clinivantage HealthcareTechnologies, a leading player providing connected healthcare ecosystem, which they facilitate through their flagship...
      Pluss Advanced Technologies partners with Drager

      Pluss Advanced Technologies partners with Drager

      Medical Dialogues Bureau13 Feb 2018 9:15 AM IST
      Pluss® Advanced Technologies, the winner of the National Technology Day Innovation Award for its patent-pending device MiraCradle® to treat Birth...
      Encouragement of Ayush Medicines: MOU between AYUSH Ministry and UK Hospital

      Encouragement of Ayush Medicines: MOU between AYUSH Ministry and UK Hospital

      Medical Dialogues Bureau12 Feb 2018 10:30 AM IST
      The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in a written reply to a question in Lok Sabha informed that CCRH has...
      Government takes measures to promote Yoga and Ayurveda across the world

      Government takes measures to promote Yoga and Ayurveda across the world

      Medical Dialogues Bureau12 Feb 2018 10:00 AM IST
      Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Lok Sabha informed about the steps taken...
      804 complaints of misleading advertisements of Ayurvedic, herbal products in 2 years

      804 complaints of misleading advertisements of Ayurvedic, herbal products in 2 years

      Medical Dialogues Bureau11 Feb 2018 10:00 AM IST
      804 complaints of misleading advertisements of Ayurvedic, herbal products have been registered in the last two years, the Minister of State...
      Jubilant Pharma gets USFDA approval for generic version of anti-viral drug

      Jubilant Pharma gets USFDA approval for generic version of anti-viral drug

      Medical Dialogues Bureau10 Feb 2018 10:30 AM IST
      New Delhi: Drug firm Jubilant Life Sciences said its subsidiary has received final approval from the US health regulator for Amantadine Hydrochloride...
      Glenmark Pharma Q3 profit falls 78 percent to Rs 104.7 crore

      Glenmark Pharma Q3 profit falls 78 percent to Rs 104.7 crore

      Medical Dialogues Bureau10 Feb 2018 10:15 AM IST
      Mumbai: Glenmark Pharmaceuticals said its net profit dropped 78 percent to Rs 104.7 crore for the quarter ended December on sharp decline of US sales,...
      Fortis Healthcare shares soar 24 percent on merger buzz

      Fortis Healthcare shares soar 24 percent on merger buzz

      Medical Dialogues Bureau9 Feb 2018 3:55 PM IST
      New Delhi: Shares of Fortis Healthcare jumped 24.5 percent amid reports that Manipal hospital, backed by TPG, is in advanced talks to merge the...
      DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns

      DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns

      Medical Dialogues Bureau9 Feb 2018 11:28 AM IST
      HYDERABAD: Dr. Reddy's Laboratories has initiated a voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok